Complete response to temozolomide in chronic lymphocytic leukemia

Area of Science:

• Oncology
• Hematology
• Neuro-oncology

Background:

• Chronic lymphocytic leukemia (CLL) is a common hematologic malignancy.
• Glioblastoma is an aggressive primary brain tumor.
• Co-occurrence of these malignancies is rare.

Observation:

• A patient diagnosed with glioblastoma incidentally had chronic lymphocytic leukemia (CLL).
• The patient received standard glioblastoma treatment, including temozolomide and cranial irradiation.
• Complete hematologic remission of CLL was observed post-treatment.

Findings:

• Standard glioblastoma treatment led to complete resolution of CLL.
• The patient's CLL did not recur during the observation period before death from glioblastoma.
• Temozolomide, a key component of the glioblastoma treatment, showed efficacy against CLL.

Implications:

• Temozolomide may represent a potential therapeutic agent for chronic lymphocytic leukemia.
• Further clinical studies are warranted to evaluate temozolomide's efficacy and safety in CLL patients.
• This case highlights the potential for repurposed therapies in hematologic malignancies.